Department of Pathology, Nantong Tumor Hospital Affiliated to Nantong University, Nantong, Jiangsu 226006, P.R. China.
Department of Pathology, Affiliated Hospital of Jining Medical University, Jining, Shandong 272029, P.R. China.
Int J Mol Med. 2024 Apr;53(4). doi: 10.3892/ijmm.2024.5364. Epub 2024 Mar 1.
SET domain bifurcated 1 (SETDB1), a pivotal histone lysine methyltransferase, is transported to the cytoplasm via a chromosome region maintenance 1 (CMR1)‑dependent pathway, contributing to non‑histone methylation. However, the function and underlying mechanism of cytoplasmic SETDB1 in breast cancer remain elusive. In the present study, immunohistochemistry revealed that elevated cytoplasmic SETDB1 was correlated with lymph node metastasis and more aggressive breast cancer subtypes. Functionally, wound healing and Transwell assays showed that cytoplasmic SETDB1 is key for cell migration and invasion, as well as induction of epithelial‑mesenchymal transition (EMT), which was reversed by leptomycin B (LMB, a CMR1 inhibitor) treatment. Furthermore, RNA‑seq and metabolite detection revealed that cytoplasmic SETDB1 was associated with metabolism pathway and elevated levels of metabolites involved in the Warburg effect, including glucose, pyruvate, lactate and ATP. Immunoblotting and reverse transcription‑quantitative PCR verified that elevation of cytoplasmic SETDB1 contributed to elevation of c‑MYC expression and subsequent upregulation of lactate dehydrogenase A (LDHA) expression. Notably, gain‑ and loss‑of‑function approaches revealed that LDHA overexpression in T47D cells enhanced migration and invasion by inducing EMT, while its depletion in SETDB1‑overexpressing MCF7 cells reversed SETDB1‑induced migration and invasion, as well as the Warburg effect and EMT. In conclusion, subcellular localization of cytoplasmic SETDB1 may be a pivotal factor in breast cancer progression. The present study offers valuable insight into the novel functions and mechanisms of cytoplasmic SETDB1.
SET 结构域分隔蛋白 1(SETDB1)是一种关键的组蛋白赖氨酸甲基转移酶,通过依赖于染色体区域维持 1(CMR1)的途径被转运到细胞质中,从而促进非组蛋白甲基化。然而,细胞质 SETDB1 在乳腺癌中的功能和潜在机制仍不清楚。在本研究中,免疫组织化学分析显示,细胞质 SETDB1 水平升高与淋巴结转移和侵袭性更强的乳腺癌亚型相关。功能上,划痕愈合和 Transwell 实验表明,细胞质 SETDB1 是细胞迁移和侵袭的关键因素,并且能够诱导上皮间质转化(EMT),而 LMB(CMR1 抑制剂)处理则逆转了这一过程。此外,RNA-seq 和代谢物检测显示,细胞质 SETDB1 与代谢途径相关,并与参与瓦博格效应的代谢物水平升高有关,包括葡萄糖、丙酮酸、乳酸和 ATP。免疫印迹和逆转录定量 PCR 验证了细胞质 SETDB1 的升高导致 c-MYC 表达的升高,随后导致乳酸脱氢酶 A(LDHA)表达的上调。值得注意的是,Gain-和 Loss-of-function 方法表明,T47D 细胞中 LDHA 的过表达通过诱导 EMT 增强了迁移和侵袭能力,而在 SETDB1 过表达的 MCF7 细胞中 LDHA 的缺失则逆转了 SETDB1 诱导的迁移和侵袭以及瓦博格效应和 EMT。综上所述,细胞质 SETDB1 的亚细胞定位可能是乳腺癌进展的关键因素。本研究为细胞质 SETDB1 的新功能和机制提供了有价值的见解。
Cell Death Dis. 2020-5-11
J Exp Clin Cancer Res. 2020-10-15
Epigenetics Chromatin. 2023-12-7
Breast Cancer (Dove Med Press). 2025-2-12
Nat Metab. 2022-12
Pigment Cell Melanoma Res. 2021-5
Biosci Biotechnol Biochem. 2020-2